Mucin-type O-glycosylation occurs on many proteins that transit the Golgi apparatus. These glycans impact structure and function of many proteins and have important roles in cellular biosynthetic processes, signaling and differentiation. Although recent technological advances have enhanced our ability to profile glycosylation of glycoproteins, limitations in the understanding of the biosynthesis of these glycan structures remain. Some of these limitations stem from the difficulty to track the biosynthetic process of mucin-type O-glycosylation, especially when glycans occur in dense clusters in repeat regions of proteins, such as the mucins or immunoglobulin A1 (IgA1). Here, we describe a series of nano-liquid chromatography (LC)-mass spectrometry (MS) analyses that demonstrate the range of glycosyltransferase enzymatic activities involved in the biosynthesis of clustered O-glycans on IgA1. By utilizing nano-LC-MS relative quantitation of in vitro reaction products, our results provide unique insights into the biosynthesis of clustered IgA1 O-glycans. We have developed a workflow to determine glycoform-specific apparent rates of a human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltrasnfersase (GalNAc-T EC 2.4.1.41) and demonstrated how pre-existing glycans affect subsequent activity of glycosyltransferases, such as core 1 galactosyltransferase and α2,3- and α2,6-specific sialyltransferases, in successive additions in the biosynthesis of clustered O-glycans. In the context of IgA1, these results have potential to provide insight into the molecular mechanisms implicated in the pathogenesis of IgA nephropathy, an autoimmune renal disease involving aberrant IgA1 O-glycosylation. In a broader sense, these methods and workflows are applicable to the studies of the concerted and competing functions of other glycosyltransferases that initiate and extend mucin-type core 1 clustered O-glycosylation.

Department of Biochemistry and Molecular Genetics University of Alabama at Birmingham 720 20th Street South KAUL 524 Birmingham AL 35294 USA

Department of Biomedical Molecular Sciences Fujita Health University School of Medicine 1 98 Dengakugakubo Kutsukake Aichi Toyoake 470 1192 Japan

Department of Immunology Palacky University and University Hospital Hnevotinska 3 Olomouc 775 15 Czech Republic

Department of Management Information Systems and Quantitative Methods 710 13th Street South University of Alabama at Birmingham Birmingham AL 35233 USA

Department of Microbiology University of Alabama at Birmingham 845 19th Street South BBRB 761A Birmingham AL 35294 USA

Optys Tech Corporation Shrewsbury MA 01545 USA

Zobrazit více v PubMed

Allen  AC, Bailey  EM, Brenchley  PE, Buck  KS, Barratt  J, Feehally  J. 2001. Mesangial IgA1 in IgA nephropathy exhibits aberrant PubMed

Baenziger  J, Kornfeld  S. 1974. Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the PubMed

Bennett  EP, Mandel  U, Clausen  H, Gerken  TA, Fritz  TA, Tabak  LA. 2012. Control of mucin-type PubMed PMC

Berrow  NS, Alderton  D, Sainsbury  S, Nettleship  J, Assenberg  R, Rahman  N, Stuart  DI, Owens  RJ. 2007. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res. 35:e45. PubMed PMC

Bevc  S, Konc  J, Stojan  J, Hodoscek  M, Penca  M, Praprotnik  M, Janezic  D. 2011. ENZO: a web tool for derivation and evaluation of kinetic models of enzyme catalyzed reactions. PLoS One. 6:e22265. PubMed PMC

Boehm  MK, Woof  JM, Kerr  MA, Perkins  SJ. 1999. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J Mol Biol. 286:1421–1447. PubMed

Brockhausen  I, Toki  D, Brockhausen  J, Peters  S, Bielfeldt  T, Kleen  A, Paulsen  H, Meldal  M, Hagen  F, Tabak  LA. 1996. Specificity of PubMed

Brockhausen  I, Yang  J, Lehotay  M, Ogata  S, Itzkowitz  S. 2001. Pathways of mucin PubMed

Dube  DH, Prescher  JA, Quang  CN, Bertozzi  CR. 2006. Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci U S A. 103:4819–4824. PubMed PMC

Elhammer  A, Kornfeld  S. 1986. Purification and characterization of UDP-N-acetylgalactosamine: polypeptide N-acetylgalactosaminyltransferase from bovine colostrum and murine lymphoma BW5147 cells. J Biol Chem. 261:5249–5255. PubMed

Franc  V, Yang  Y, Heck  AJ. 2017. Proteoform profile mapping of the human serum complement component C9 revealing unexpected new features of N-, O-, and C-glycosylation. Anal Chem. 89:3483–3491. PubMed PMC

Fritz  TA, Raman  J, Tabak  LA. 2006. Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide α- PubMed

Gasteiger  E, Hoogland  C, Gattiker  A, Duvaud  S, Wilkins  MR, Appel  RD, Bairoch  A. 2005. Protein Identification and Analysis Tools on the ExPASy Server. In: Walker  JM, editor. Protein Identification and Analysis Tools on the ExPASy Server. Totowa, NJ: Humana Press. p. 571–607.

Gerken  TA. 2004. Kinetic modeling confirms the biosynthesis of mucin core 1 β-Gal(1-3) α-GalNAc-O-Ser/Thr PubMed

Gerken  TA, Owens  CL, Pasumarthy  M. 1998. Site-specific core 1 PubMed

Gerken  TA, Zhang  J, Levine  J, Elhammer  A. 2002. Mucin core PubMed

Hagopian  A, Westall  FC, Whitehead  JS, Eylar  EH. 1971. Glycosylation of the A1 protein from myelin by a polypeptide PubMed

Hang  HC, Yu  C, Kato  DL, Bertozzi  CR. 2003. A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc Natl Acad Sci U S A. 100:14846–14851. PubMed PMC

Hanisch  FG. 2001. PubMed

Hanisch  FG, Jovanovic  M, Peter-Katalinic  J. 2001a. Glycoprotein identification and localization of PubMed

Hanisch  FG, Muller  S, Hassan  H, Clausen  H, Zachara  N, Gooley  AA, Paulsen  H, Alving  K, Peter-Katalinic  J. 1999. Dynamic epigenetic regulation of initial PubMed

Hanisch  FG, Reis  CA, Clausen  H, Paulsen  H. 2001b. Evidence for glycosylation-dependent activities of polypeptide PubMed

Hargett  AA, Renfrow  MB. 2019. Glycosylation of viral surface proteins probed by mass spectrometry. Curr Opin Virol. 36:56–66. PubMed PMC

Hargett  AA, Wei  Q, Knoppova  B, Hall  S, Huang  ZQ, Prakash  A, Green  TJ, Moldoveanu  Z, Raska  M, Novak  J, et al.  2019. Defining HIV-1 envelope PubMed PMC

Hennebicq  S, Tetaert  D, Soudan  B, Boersma  A, Briand  G, Richet  C, Gagnon  J, Degand  P. 1998. Influence of the amino acid sequence on the MUC5AC motif peptide PubMed

Hiki  Y, Odani  H, Takahashi  M, Yasuda  Y, Nishimoto  A, Iwase  H, Shinzato  T, Kobayashi  Y, Maeda  K. 2001. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59:1077–1085. PubMed

Horynova  M, Takahashi  K, Hall  S, Renfrow  MB, Novak  J, Raska  M. 2012. Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igkappa in insect cells. Protein Expr Purif. 81:175–180. PubMed PMC

Iida  S, Takeuchi  H, Hassan  H, Clausen  H, Irimura  T. 1999. Incorporation of PubMed

Iida  S, Takeuchi  H, Kato  K, Yamamoto  K, Irimura  T. 2000. Order and maximum incorporation of PubMed PMC

Iwasaki  H, Zhang  Y, Tachibana  K, Gotoh  M, Kikuchi  N, Kwon  YD, Togayachi  A, Kudo  T, Kubota  T, Narimatsu  H. 2003. Initiation of PubMed

Kato  K, Takeuchi  H, Kanoh  A, Mandel  U, Hassan  H, Clausen  H, Irimura  T. 2001a. PubMed

Kato  K, Takeuchi  H, Miyahara  N, Kanoh  A, Hassan  H, Clausen  H, Irimura  T. 2001b. Distinct orders of GalNAc incorporation into a peptide with consecutive threonines. Biochem Biophys Res Commun. 287:110–115. PubMed

Kiryluk  K, Li  Y, Moldoveanu  Z, Suzuki  H, Reily  C, Hou  P, Xie  J, Mladkova  N, Prakash  S, Fischman  C, et al.  2017. GWAS for serum galactose-deficient IgA1 implicates critical genes of the PubMed PMC

Knoppova  B, Reily  C, Maillard  N, Rizk  DV, Moldoveanu  Z, Mestecky  J, Raska  M, Renfrow  MB, Julian  BA, Novak  J. 2016. The origin and activities of IgA1-containing immune complexes in IgA nephropathy. Front Immunol. 7:117. PubMed PMC

Marth  JD, Grewal  PK. 2008. Mammalian glycosylation in immunity. Nat Rev Immunol. 8:874–887. PubMed PMC

Mattu  TS, Pleass  RJ, Willis  AC, Kilian  M, Wormald  MR, Lellouch  AC, Rudd  PM, Woof  JM, Dwek  RA. 1998. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of PubMed

Mestecky  J, Kilian  M. 1985. Immunoglobulin A (IgA). Methods Enzymol. 116:37–75. PubMed

Mestecky  J, Tomana  M, Crowley-Nowick  PA, Moldoveanu  Z, Julian  BA, Jackson  S. 1993. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol. 104:172–182. PubMed

Moldoveanu  Z, Wyatt  RJ, Lee  JY, Tomana  M, Julian  BA, Mestecky  J, Huang  WQ, Anreddy  SR, Hall  S, Hastings  MC, et al.  2007. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 71:1148–1154. PubMed

Moore  JS, Kulhavy  R, Tomana  M, Moldoveanu  Z, Suzuki  H, Brown  R, Hall  S, Kilian  M, Poulsen  K, Mestecky  J, et al.  2007. Reactivities of PubMed PMC

Muller  S, Hanisch  FG. 2002. Recombinant MUC1 probe authentically reflects cell-specific PubMed

Novak  J, Julian  BA, Mestecky  J, Renfrow  MB. 2012. Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol. 34:365–382. PubMed

Novak  J, Julian  BA, Tomana  M, Mesteck  J. 2001. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol. 21:310–327. PubMed

Nwosu  CC, Seipert  RR, Strum  JS, Hua  SS, An  HJ, Zivkovic  AM, German  BJ, Lebrilla  CB. 2011. Simultaneous and extensive site-specific PubMed PMC

O'Connell  BC, Hagen  FK, Tabak  LA. 1992. The influence of flanking sequence on the PubMed

Ohyama  Y, Nakajima  K, Renfrow  MB, Novak  J, Takahashi  K. 2020. Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins. Expert Rev Proteomics. 17:275–296. PubMed PMC

Parry  S, Hanisch  FG, Leir  SH, Sutton-Smith  M, Morris  HR, Dell  A, Harris  A. 2006. PubMed

Pedersen  JW, Bennett  EP, Schjoldager  KT, Meldal  M, Holmér  AP, Blixt  O, Cló  E, Levery  SB, Clausen  H, Wandall  HH. 2011. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity. J Biol Chem. 286:32684–32696. PubMed PMC

Peter-Katalinic  J. 2005. Methods in enzymology: PubMed

Pratt  MR, Hang  HC, Ten Hagen  KG, Rarick  J, Gerken  TA, Tabak  LA, Bertozzi  CR. 2004. Deconvoluting the functions of polypeptide PubMed

Raman  J, Fritz  TA, Gerken  TA, Jamison  O, Live  D, Liu  M, Tabak  LA. 2008. The catalytic and lectin domains of UDP-GalNAc:polypeptide α- PubMed PMC

Raska  M, Moldoveanu  Z, Suzuki  H, Brown  R, Kulhavy  R, Andrasi  J, Hall  S, Vu  HL, Carlsson  F, Lindahl  G, et al.  2007. Identification and characterization of CMP-NeuAc:GalNAc-IgA1 α2,6-sialyltransferase in IgA1-producing cells. J Mol Biol. 369:69–78. PubMed PMC

Reily  C, Stewart  TJ, Renfrow  MB, Novak  J. 2019. Glycosylation in health and disease. Nat Rev Nephrol. 15:346–366. PubMed PMC

Renfrow  MB, Cooper  HJ, Tomana  M, Kulhavy  R, Hiki  Y, Toma  K, Emmett  MR, Mestecky  J, Marshall  AG, Novak  J. 2005. Determination of aberrant PubMed

Renfrow  MB, Mackay  CL, Chalmers  MJ, Julian  BA, Mestecky  J, Kilian  M, Poulsen  K, Emmett  MR, Marshall  AG, Novak  J. 2007. Analysis of PubMed

Revoredo  L, Wang  S, Bennett  EP, Clausen  H, Moremen  KW, Jarvis  DL, Ten Hagen  KG, Tabak  LA, Gerken  TA. 2016. Mucin-type PubMed PMC

Rizk  DV, Saha  MK, Hall  S, Novak  L, Brown  R, Huang  ZQ, Fatima  H, Julian  BA, Novak  J. 2019. Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1. J Am Soc Nephrol. 30:2017–2026. PubMed PMC

Roth  J. 1987. Subcellular organization of glycosylation in mammalian cells. Biochim Biophys Acta. 906:405–436. PubMed

Rottger  S, White  J, Wandall  HH, Olivo  JC, Stark  A, Bennett  EP, Whitehouse  C, Berger  EG, Clausen  H, Nilsson  T. 1998. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of PubMed

Schjoldager  KT, Narimatsu  Y, Joshi  HJ, Clausen  H. 2020. Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol. 21:729–749. PubMed

Sheta  R, Woo  CM, Roux-Dalvai  F, Fournier  F, Bourassa  S, Droit  A, Bertozzi  CR, Bachvarov  D. 2016. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. J Proteomics. 145:91–102. PubMed PMC

Soudan  B, Hennebicq  S, Tetaert  D, Boersma  A, Richet  C, Demeyer  D, Briand  G, Degand  P. 1999. Capillary zone electrophoresis and MALDI-mass spectrometry for the monitoring of in vitro PubMed

Stadie  TR, Chai  W, Lawson  AM, Byfield  PG, Hanisch  FG. 1995. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide PubMed

Stewart  TJ, Takahashi  K, Whitaker  RH, Raska  M, Placzek  WJ, Novak  J, Renfrow  MB. 2019. IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2. Glycobiology. 29:543–556. PubMed PMC

Stuchlova Horynova  M, Vrablikova  A, Stewart  TJ, Takahashi  K, Czernekova  L, Yamada  K, Suzuki  H, Julian  BA, Renfrow  MB, Novak  J, et al.  2015. PubMed PMC

Suzuki  H, Fan  R, Zhang  Z, Brown  R, Hall  S, Julian  BA, Chatham  WW, Suzuki  Y, Wyatt  RJ, Moldoveanu  Z, et al.  2009. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 119:1668–1677. PubMed PMC

Suzuki  H, Moldoveanu  Z, Hall  S, Brown  R, Vu  HL, Novak  L, Julian  BA, Tomana  M, Wyatt  RJ, Edberg  JC, et al.  2008. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 118:629–639. PubMed PMC

Suzuki  H, Raska  M, Yamada  K, Moldoveanu  Z, Julian  BA, Wyatt  RJ, Tomino  Y, Gharavi  AG, Novak  J. 2014. Cytokines alter IgA1 PubMed PMC

Syka  JE, Coon  JJ, Schroeder  MJ, Shabanowitz  J, Hunt  DF. 2004. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A. 101:9528–9533. PubMed PMC

Takahashi  K, Raska  M, Stuchlova Horynova  M, Hall  SD, Poulsen  K, Kilian  M, Hiki  Y, Yuzawa  Y, Moldoveanu  Z, Julian  BA, et al.  2014. Enzymatic sialylation of IgA1 PubMed PMC

Takahashi  K, Smith  AD, Poulsen  K, Kilian  M, Julian  BA, Mestecky  J, Novak  J, Renfrow  MB. 2012. Naturally occurring structural isomers in serum IgA1 PubMed PMC

Takahashi  K, Wall  SB, Suzuki  H, ADt  S, Hall  S, Poulsen  K, Kilian  M, Mobley  JA, Julian  BA, Mestecky  J, et al.  2010. Clustered PubMed PMC

Takeuchi  H, Kato  K, Hassan  H, Clausen  H, Irimura  T. 2002. PubMed

Ten Hagen  KG, Bedi  GS, Tetaert  D, Kingsley  PD, Hagen  FK, Balys  MM, Beres  TM, Degand  P, Tabak  LA. 2001. Cloning and characterization of a ninth member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, ppGaNTase-T9. J Biol Chem. 276:17395–17404. PubMed

Ten Hagen  KG, Fritz  TA, Tabak  LA. 2003. All in the family: the UDP-GalNAc:polypeptide PubMed

Ten Hagen  KG, Tetaert  D, Hagen  FK, Richet  C, Beres  TM, Gagnon  J, Balys  MM, VanWuyckhuyse  B, Bedi  GS, Degand  P, et al.  1999. Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity. J Biol Chem. 274:27867–27874. PubMed

Tomana  M, Matousovic  K, Julian  BA, Radl  J, Konecny  K, Mestecky  J. 1997. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52:509–516. PubMed

Tomana  M, Novak  J, Julian  BA, Matousovic  K, Konecny  K, Mestecky  J. 1999. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 104:73–81. PubMed PMC

Wada  Y, Dell  A, Haslam  SM, Tissot  B, Canis  K, Azadi  P, Backstrom  M, Costello  CE, Hansson  GC, Hiki  Y, et al.  2010. Comparison of methods for profiling PubMed PMC

Wandall  HH, Hassan  H, Mirgorodskaya  E, Kristensen  AK, Roepstorff  P, Bennett  EP, Nielsen  PA, Hollingsworth  MA, Burchell  J, Taylor-Papadimitriou  J, et al.  1997. Substrate specificities of three members of the human UDP- PubMed

Wandall  HH, Irazoqui  F, Tarp  MA, Bennett  EP, Mandel  U, Takeuchi  H, Kato  K, Irimura  T, Suryanarayanan  G, Hollingsworth  MA, et al.  2007. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation. Glycobiology. 17:374–387. PubMed

Wragg  S, Hagen  FK, Tabak  LA. 1995. Kinetic analysis of a recombinant UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase. J Biol Chem. 270:16947–16954. PubMed

Xiao  J, Wang  M, Xiong  D, Wang  Y, Li  Q, Zhou  J, Chen  Q. 2017. TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1,3-galactosyltransferase and Cosmc. Mol Med Rep. 15:969–974. PubMed

Xing  Y, Li  L, Zhang  Y, Wang  F, He  D, Liu  Y, Jia  J, Yan  T, Lin  S. 2020. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy. BMC Nephrol. 21:18. PubMed PMC

Yanagawa  H, Suzuki  H, Suzuki  Y, Kiryluk  K, Gharavi  AG, Matsuoka  K, Makita  Y, Julian  BA, Novak  J, Tomino  Y. 2014. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. PLoS One. 9:e98081. PubMed PMC

Yang  Y, Liu  F, Franc  V, Halim  LA, Schellekens  H, Heck  AJ. 2016. Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity. Nat Commun. 7:13397. PubMed PMC

Yang  Z, Wang  S, Halim  A, Schulz  MA, Frodin  M, Rahman  SH, Vester-Christensen  MB, Behrens  C, Kristensen  C, Vakhrushev  SY, et al.  2015. Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat Biotechnol. 33:842–844. PubMed

GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy